{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:40:14Z","timestamp":1790638814213,"version":"4.1.0"},"reference-count":87,"publisher":"Wiley","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"EuFMD"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transbound Emerg Dis"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1111\/tbed.12521","type":"journal-article","created":{"date-parts":[[2016,6,20]],"date-time":"2016-06-20T06:48:32Z","timestamp":1466405312000},"page":"30-41","source":"Crossref","is-referenced-by-count":48,"special_numbering":"supplement S1","title":["Global Foot-and-Mouth Disease Research Update and Gap Analysis: 3 - Vaccines"],"prefix":"10.1155","volume":"63","author":[{"given":"L.","family":"Robinson","sequence":"first","affiliation":[{"name":"Insight Editing London; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. J. D.","family":"Knight-Jones","sequence":"additional","affiliation":[{"name":"International Livestock Research Institute (ILRI); Lusaka Zambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Charleston","sequence":"additional","affiliation":[{"name":"The Pirbright Institute; Pirbright UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. L.","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Plum Island Animal Disease Center; ARS; USDA; Greenport NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. G.","family":"Gay","sequence":"additional","affiliation":[{"name":"Agricultural Research Service; USDA; National Program 103-Animal Health; Beltsville MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. J.","family":"Sumption","sequence":"additional","affiliation":[{"name":"European Commission for the Control of FMD (EuFMD); FAO; Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Vosloo","sequence":"additional","affiliation":[{"name":"Australian Animal Health Laboratory; CSIRO-Biosecurity Flagship; Geelong Vic. Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,6,20]]},"reference":[{"key":"10.1111\/tbed.12521-BIB0001|tbed12521-cit-0001","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1016\/j.vaccine.2014.08.033","article-title":"Genetic and antigenic characterisation of serotype A FMD viruses from East Africa to select new vaccine strains","volume":"32","author":"Bari","year":"2014","journal-title":"Vaccine"},{"key":"10.1111\/tbed.12521-BIB0002|tbed12521-cit-0002","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1099\/vir.0.000051","article-title":"Prediction and characterization of novel epitopes of serotype A foot-and-mouth disease viruses circulating in East Africa using site-directed mutagenesis","volume":"96","author":"Bari","year":"2015","journal-title":"J. Gen. Virol."},{"key":"10.1111\/tbed.12521-BIB0003|tbed12521-cit-0003","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0264-410X(91)90261-4","article-title":"Developments in foot-and-mouth disease vaccines","volume":"9","author":"Barteling","year":"1991","journal-title":"Vaccine"},{"key":"10.1111\/tbed.12521-BIB0004|tbed12521-cit-0004","doi-asserted-by":"crossref","first-page":"8735","DOI":"10.1128\/JVI.01138-13","article-title":"Positively charged residues at the five-fold symmetry axis of cell culture-adapted foot-and-mouth disease virus permit novel receptor interactions","volume":"87","author":"Berryman","year":"2013","journal-title":"J. Virol."},{"key":"10.1111\/tbed.12521-BIB0005|tbed12521-cit-0005","doi-asserted-by":"crossref","first-page":"475960","DOI":"10.1155\/2013\/475960","article-title":"B epitope multiplicity and B\/T epitope orientation influence immunogenicity of foot-and-mouth disease peptide vaccines","volume":"2013","author":"Blanco","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1111\/tbed.12521-BIB0006|tbed12521-cit-0006","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1099\/vir.0.027151-0","article-title":"Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs","volume":"92","author":"Blignaut","year":"2011","journal-title":"J. Gen. Virol."},{"key":"10.1111\/tbed.12521-BIB0007|tbed12521-cit-0007","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1016\/j.vaccine.2013.07.008","article-title":"Delivery of synthetic RNA can enhance the immunogenicity of vaccines against foot-and-mouth disease virus (FMDV) in mice","volume":"31","author":"Borrego","year":"2013","journal-title":"Vaccine"},{"key":"10.1111\/tbed.12521-BIB0008|tbed12521-cit-0008","first-page":"123","article-title":"Human adenovirus-vectored foot-and-mouth disease vaccines: establishment of a vaccine product profile through in\u00a0vitro testing","volume":"134","author":"Brake","year":"2012","journal-title":"Dev. Biol. (Basel)"},{"key":"10.1111\/tbed.12521-BIB0009|tbed12521-cit-0009","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.vaccine.2013.12.007","article-title":"Accuracy of traditional and novel serology tests for predicting cross-protection in foot-and-mouth disease vaccinated cattle","volume":"32","author":"Brito","year":"2014","journal-title":"Vaccine"},{"key":"10.1111\/tbed.12521-BIB0010|tbed12521-cit-0010","doi-asserted-by":"crossref","first-page":"6966","DOI":"10.1016\/j.vaccine.2006.04.050","article-title":"Comparative evaluation of six ELISAs for the detection of antibodies to the non-structural proteins of foot-and-mouth disease virus","volume":"24","author":"Brocchi","year":"2006","journal-title":"Vaccine"},{"key":"10.1111\/tbed.12521-BIB0011|tbed12521-cit-0011","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1586\/14760584.2014.963562","article-title":"Adjuvants for foot-and-mouth disease virus vaccines: recent progress","volume":"13","author":"Cao","year":"2014","journal-title":"Expert. Rev. Vaccines"},{"key":"10.1111\/tbed.12521-BIB0012|tbed12521-cit-0012","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jviromet.2012.03.036","article-title":"Improved neutralising antibody response against foot-and-mouth-disease virus in mice inoculated with a multi-epitope peptide vaccine using polyinosinic and poly-cytidylic acid as an adjuvant","volume":"185","author":"Cao","year":"2012","journal-title":"J. Virol. Methods"},{"key":"10.1111\/tbed.12521-BIB0013|tbed12521-cit-0013","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.antiviral.2012.11.009","article-title":"Poly(I:C) combined with multi-epitope protein vaccine completely protects against virulent foot-and-mouth disease virus challenge in pigs","volume":"97","author":"Cao","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1111\/tbed.12521-BIB0014|tbed12521-cit-0014","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1099\/jgv.0.000222","article-title":"Identification of a novel cell culture adaptation site on the capsid of foot-and-mouth disease virus","volume":"96","author":"Chamberlain","year":"2015","journal-title":"J. Gen. Virol."},{"key":"10.1111\/tbed.12521-BIB0015|tbed12521-cit-0015","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.rvsc.2013.11.017","article-title":"Adjuvant effect enhancement of porcine interleukin-2 packaged into solid lipid nanoparticles","volume":"96","author":"Chen","year":"2014","journal-title":"Res. Vet. Sci."},{"key":"10.1111\/tbed.12521-BIB0016|tbed12521-cit-0016","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.1996.03530290060038","article-title":"Evaluating new vaccines for developing countries. Efficacy or effectiveness?","volume":"275","author":"Clemens","year":"1996","journal-title":"JAMA"},{"key":"10.1111\/tbed.12521-BIB0017|tbed12521-cit-0017","unstructured":"Council Directive 2001 2001\/82\/EC - Directive 2001\/82\/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products (Official Journal L 311, 28\/11\/2001 p. 1 - 66)"},{"key":"10.1111\/tbed.12521-BIB0018|tbed12521-cit-0018","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.virol.2014.08.012","article-title":"Poly ICLC increases the potency of a replication-defective human adenovirus vectored foot-and-mouth disease vaccine","volume":"468-470","author":"Diaz-San Segundo","year":"2014","journal-title":"Virology"},{"key":"10.1111\/tbed.12521-BIB0019|tbed12521-cit-0019","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0168-1702(02)00261-7","article-title":"FMD vaccines","volume":"91","author":"Doel","year":"2003","journal-title":"Virus Res."},{"key":"10.1111\/tbed.12521-BIB0021|tbed12521-cit-0021","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.vaccine.2012.12.011","article-title":"The field effectiveness of routine and emergency vaccination with an inactivated vaccine against foot and mouth disease","volume":"31","author":"Elnekave","year":"2013","journal-title":"Vaccine"},{"key":"10.1111\/tbed.12521-BIB0022|tbed12521-cit-0022","unstructured":"European Medicines Agency 2003 Committee for veterinary medicinal products - revised position paper on indications for veterinary vaccines-EMEA\/CVMP\/042\/97-Rev.1-FINAL"},{"key":"10.1111\/tbed.12521-BIB0023|tbed12521-cit-0023","first-page":"591","volume-title":"Evaluation of Efficacy of Veterinary Vaccines and Immunosera","author":"European pharmacopoeia","year":"2012","edition":"8"},{"key":"10.1111\/tbed.12521-BIB0024|tbed12521-cit-0024","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cellimm.2013.02.004","article-title":"Enhancement of the immune responses to foot-and-mouth disease vaccination in mice by oral administration of a novel polysaccharide from the roots of Radix Cyathulae officinalis Kuan (RC)","volume":"281","author":"Feng","year":"2013","journal-title":"Cell. Immunol."},{"key":"10.1111\/tbed.12521-BIB0025|tbed12521-cit-0025","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijbiomac.2014.01.017","article-title":"Novel polysaccharide from Radix Cyathulae officinalis Kuan can improve immune response to ovalbumin in mice","volume":"65","author":"Feng","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1111\/tbed.12521-BIB0026|tbed12521-cit-0026","unstructured":"GFRA 2010 Foot-and-mouth Disease Gap Analysis (Workshop Report) http:\/\/www.ars.usda.gov\/GFRA\/reports\/NVS-FMD%20Gap%20Analysis%20Workshop%20Report%20December%202010.pdf"},{"key":"10.1111\/tbed.12521-BIB0027|tbed12521-cit-0027","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1016\/j.vaccine.2006.12.049","article-title":"European Pharmacopoeia foot-and-mouth disease vaccine potency testing in cattle: between test variability and its consequences","volume":"25","author":"Goris","year":"2007","journal-title":"Vaccine"},{"key":"10.1111\/tbed.12521-BIB0028|tbed12521-cit-0028","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2217\/fvl.09.68","article-title":"Adenovirus serotype 5-vectored foot-and-mouth disease subunit vaccines: the first decade","volume":"5","author":"Grubman","year":"2010","journal-title":"Future Virol."},{"key":"10.1111\/tbed.12521-BIB0029|tbed12521-cit-0029","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1099\/vir.0.054122-0","article-title":"Assembly and characterization of foot-and-mouth disease virus empty capsid particles expressed within mammalian cells","volume":"94","author":"Gullberg","year":"2013","journal-title":"J. Gen. Virol."},{"key":"10.1111\/tbed.12521-BIB0030|tbed12521-cit-0030","doi-asserted-by":"crossref","first-page":"235ra261","DOI":"10.1126\/scitranslmed.3007909","article-title":"CpG ODN nanorings induce IFNalpha from plasmacytoid dendritic cells and demonstrate potent vaccine adjuvant activity","volume":"6","author":"Gungor","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1111\/tbed.12521-BIB0031|tbed12521-cit-0031","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1297-9716-44-48","article-title":"Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle","volume":"44","author":"Guo","year":"2013","journal-title":"Vet. Res."},{"key":"10.1111\/tbed.12521-BIB0032|tbed12521-cit-0032","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/tbed.12051","article-title":"Proper quality control of formulated foot-and-mouth disease vaccines in countries with prophylactic vaccination is necessary","volume":"61","author":"Jamal","year":"2014","journal-title":"Transbound Emerg. Dis."},{"key":"10.1111\/tbed.12521-BIB0033|tbed12521-cit-0033","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4110\/in.2013.13.4.157","article-title":"Targeted Delivery of VP1 Antigen of Foot-and-mouth Disease Virus to M Cells Enhances the Antigen-specific Systemic and Mucosal Immune Response","volume":"13","author":"Kim","year":"2013","journal-title":"Immune Netw."},{"key":"10.1111\/tbed.12521-BIB0034|tbed12521-cit-0034","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.prevetmed.2013.07.013","article-title":"The economic impacts of foot and mouth disease - what are they, how big are they and where do they occur?","volume":"112","author":"Knight-Jones","year":"2013","journal-title":"Prev. Vet. Med."},{"key":"10.1111\/tbed.12521-BIB0035|tbed12521-cit-0035","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.vaccine.2014.01.071","article-title":"Retrospective evaluation of foot-and-mouth disease vaccine effectiveness in Turkey","volume":"32","author":"Knight-Jones","year":"2014a","journal-title":"Vaccine"},{"key":"10.1111\/tbed.12521-BIB0036|tbed12521-cit-0036","doi-asserted-by":"crossref","first-page":"20132839","DOI":"10.1098\/rspb.2013.2839","article-title":"Veterinary and human vaccine evaluation methods","volume":"281","author":"Knight-Jones","year":"2014b","journal-title":"Proc. Biol. Sci."},{"key":"10.1111\/tbed.12521-BIB0037|tbed12521-cit-0037","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.vaccine.2014.12.010","article-title":"Randomised field trial to evaluate serological response after foot-and-mouth disease vaccination in Turkey","volume":"33","author":"Knight-Jones","year":"2015","journal-title":"Vaccine"},{"key":"10.1111\/tbed.12521-BIB0038|tbed12521-cit-0038","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nsmb.3096","article-title":"Structure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine design","volume":"22","author":"Kotecha","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1111\/tbed.12521-BIB0039|tbed12521-cit-0039","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.1016\/j.vaccine.2012.09.011","article-title":"Avidity and subtyping of specific antibodies applied to the indirect assessment of heterologous protection against Foot-and-Mouth Disease Virus in cattle","volume":"30","author":"Lavoria","year":"2012","journal-title":"Vaccine"},{"key":"10.1111\/tbed.12521-BIB0040|tbed12521-cit-0040","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.vetmic.2013.02.012","article-title":"Serological responses after vaccination of growing pigs with foot-and-mouth disease trivalent (type O, A and Asia1) vaccine","volume":"164","author":"Lee","year":"2013","journal-title":"Vet. Microbiol."},{"key":"10.1111\/tbed.12521-BIB0041|tbed12521-cit-0041","doi-asserted-by":"crossref","first-page":"477","DOI":"10.20506\/rst.21.3.1345","article-title":"Review of the status of foot and mouth disease and approach to control\/eradication in Europe and Central Asia","volume":"21","author":"Leforban","year":"2002","journal-title":"Rev. Sci. Tech."},{"key":"10.1111\/tbed.12521-BIB0042|tbed12521-cit-0042","doi-asserted-by":"crossref","first-page":"917","DOI":"10.20506\/rst.33.3.2329","article-title":"Effectiveness of systematic foot and mouth disease mass vaccination campaigns in Argentina","volume":"33","author":"Leon","year":"2014","journal-title":"Rev. Sci. Tech."},{"key":"10.1111\/tbed.12521-BIB0043|tbed12521-cit-0043","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.virusres.2014.07.013","article-title":"Presentation of epitope sequences from foreign viruses on the surface of apple latent spherical virus particles","volume":"190","author":"Li","year":"2014a","journal-title":"Virus Res."},{"key":"10.1111\/tbed.12521-BIB0044|tbed12521-cit-0044","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1297-9716-45-51","article-title":"Evaluation of a 3A-truncated foot-and-mouth disease virus in pigs for its potential as a marker vaccine","volume":"45","author":"Li","year":"2014b","journal-title":"Vet. Res."},{"key":"10.1111\/tbed.12521-BIB0045|tbed12521-cit-0045","doi-asserted-by":"crossref","first-page":"e84443","DOI":"10.1371\/journal.pone.0084443","article-title":"Identification of cytotoxic T lymphocyte epitopes on swine viruses: multi-epitope design for universal T cell vaccine","volume":"8","author":"Liao","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1111\/tbed.12521-BIB0046|tbed12521-cit-0046","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1099\/vir.0.057521-0","article-title":"Antigenic variation of foot-and-mouth disease virus serotype A","volume":"95","author":"Ludi","year":"2014","journal-title":"J. Gen. Virol."},{"key":"10.1111\/tbed.12521-BIB0047|tbed12521-cit-0047","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.actatropica.2014.09.010","article-title":"Epidemiological analysis of an outbreak of foot-and-mouth disease (serotype SAT2) on a large dairy farm in Kenya using regular vaccination","volume":"143","author":"Lyons","year":"2015","journal-title":"Acta Trop."},{"key":"10.1111\/tbed.12521-BIB0048|tbed12521-cit-0048","doi-asserted-by":"crossref","first-page":"8230","DOI":"10.1016\/j.vaccine.2011.08.120","article-title":"Characterization of foot-and-mouth disease virus from outbreaks in Ecuador during 2009-2010 and cross-protection studies with the vaccine strain in use in the region","volume":"29","author":"Maradei","year":"2011","journal-title":"Vaccine"},{"key":"10.1111\/tbed.12521-BIB0049|tbed12521-cit-0049","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.vetmic.2012.10.035","article-title":"Characterization of a type O foot-and-mouth disease virus re-emerging in the year 2011 in free areas of the Southern Cone of South America and cross-protection studies with the vaccine strain in use in the region","volume":"162","author":"Maradei","year":"2013","journal-title":"Vet. Microbiol."},{"key":"10.1111\/tbed.12521-BIB0050|tbed12521-cit-0050","doi-asserted-by":"crossref","first-page":"e61612","DOI":"10.1371\/journal.pone.0061612","article-title":"Analysis of SAT type foot-and-mouth disease virus capsid proteins and the identification of putative amino acid residues affecting virus stability","volume":"8","author":"Maree","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1111\/tbed.12521-BIB0051|tbed12521-cit-0051","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1016\/j.vaccine.2015.04.058","article-title":"Intra-serotype SAT2 chimeric foot-and-mouth disease vaccine protects cattle against FMDV challenge","volume":"33","author":"Maree","year":"2015","journal-title":"Vaccine"},{"key":"10.1111\/tbed.12521-BIB0052|tbed12521-cit-0052","unstructured":"Metwally , S. S. Munstermann G. Ferrari D. J. Paton S. J. Duffy C. J. Bartels T. J. D. Knight-Jones OIE-FAO Foot and mouth disease post-vaccination monitoring guidelines"},{"key":"10.1111\/tbed.12521-BIB0053|tbed12521-cit-0053","doi-asserted-by":"crossref","first-page":"e72800","DOI":"10.1371\/journal.pone.0072800","article-title":"Transient gene expression in serum-free suspension-growing mammalian cells for the production of foot-and-mouth disease virus empty capsids","volume":"8","author":"Mignaqui","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1111\/tbed.12521-BIB0054|tbed12521-cit-0054","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.vaccine.2012.12.001","article-title":"A proposal for an alternative quality control test procedure for inactivated vaccines against food-and-mouth disease virus","volume":"31","author":"Molin-Capeti","year":"2013","journal-title":"Vaccine"},{"key":"10.1111\/tbed.12521-BIB0055|tbed12521-cit-0055","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/S0264-410X(01)00483-2","article-title":"Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24","volume":"20","author":"Moraes","year":"2002","journal-title":"Vaccine"},{"key":"10.1111\/tbed.12521-BIB0056|tbed12521-cit-0056","doi-asserted-by":"crossref","first-page":"9431","DOI":"10.1016\/j.vaccine.2011.10.037","article-title":"Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response","volume":"29","author":"Moraes","year":"2011","journal-title":"Vaccine"},{"key":"10.1111\/tbed.12521-BIB0057|tbed12521-cit-0057","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.biologicals.2014.01.002","article-title":"Immunological evaluation of mannosylated chitosan nanoparticles based foot and mouth disease virus DNA vaccine, pVAC FMDV VP1-OmpA in guinea pigs","volume":"42","author":"Nanda","year":"2014","journal-title":"Biologicals"},{"key":"10.1111\/tbed.12521-BIB0058|tbed12521-cit-0058","doi-asserted-by":"crossref","first-page":"20120381","DOI":"10.1098\/rstb.2012.0381","article-title":"Elimination of foot-and-mouth disease in South America: lessons and challenges","volume":"368","author":"Naranjo","year":"2013","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1111\/tbed.12521-BIB0059|tbed12521-cit-0059","volume-title":"Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2013","author":"OIE","year":"2013"},{"key":"10.1111\/tbed.12521-BIB0060|tbed12521-cit-0060","volume-title":"Manual of Diagnostic Tests and Vaccines for Terrestrial Animals","author":"OIE","year":"2015"},{"key":"10.1111\/tbed.12521-BIB0061|tbed12521-cit-0061","doi-asserted-by":"crossref","first-page":"5603","DOI":"10.2147\/IJN.S72318","article-title":"Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles","volume":"9","author":"Pan","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1111\/tbed.12521-BIB0062|tbed12521-cit-0062","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1586\/14760584.8.3.347","article-title":"Vaccination against foot-and-mouth disease virus: strategies and effectiveness","volume":"8","author":"Parida","year":"2009","journal-title":"Expert. Rev. Vaccines"},{"key":"10.1111\/tbed.12521-BIB0063|tbed12521-cit-0063","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1016\/j.vaccine.2014.07.040","article-title":"Enhanced immune responses of foot-and-mouth disease vaccine using new oil\/gel adjuvant mixtures in pigs and goats","volume":"32","author":"Park","year":"2014","journal-title":"Vaccine"},{"key":"10.1111\/tbed.12521-BIB0064|tbed12521-cit-0064","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.1016\/j.vaccine.2006.06.032","article-title":"Application of non-structural protein antibody tests in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle","volume":"24","author":"Paton","year":"2006","journal-title":"Vaccine"},{"key":"10.1111\/tbed.12521-BIB0065|tbed12521-cit-0065","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/B978-0-12-429601-5.50011-3","volume-title":"Applied virology","author":"Pay","year":"1984"},{"key":"10.1111\/tbed.12521-BIB0066|tbed12521-cit-0066","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.1016\/j.vaccine.2008.08.022","article-title":"Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine","volume":"26","author":"Pena","year":"2008","journal-title":"Vaccine"},{"key":"10.1111\/tbed.12521-BIB0067|tbed12521-cit-0067","unstructured":"Perez-Martin , E. 2014 Use of specific Llama antibodies for quality control testing of FMD vaccines. oral presentation at the EuFMD OPen Session, Cavtat, Croatia 29-31 October 2014"},{"key":"10.1111\/tbed.12521-BIB0068|tbed12521-cit-0068","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1099\/vir.0.050492-0","article-title":"Low levels of foot-and-mouth disease virus 3C protease expression are required to achieve optimal capsid protein expression and processing in mammalian cells","volume":"94","author":"Polacek","year":"2013","journal-title":"J. Gen. Virol."},{"key":"10.1111\/tbed.12521-BIB0069|tbed12521-cit-0069","doi-asserted-by":"crossref","first-page":"e1003255","DOI":"10.1371\/journal.ppat.1003255","article-title":"Rational engineering of recombinant picornavirus capsids to produce safe, protective vaccine antigen","volume":"9","author":"Porta","year":"2013a","journal-title":"PLoS Pathog."},{"key":"10.1111\/tbed.12521-BIB0070|tbed12521-cit-0070","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jviromet.2012.11.011","article-title":"Efficient production of foot-and-mouth disease virus empty capsids in insect cells following down regulation of 3C protease activity","volume":"187","author":"Porta","year":"2013b","journal-title":"J. Virol. Methods"},{"key":"10.1111\/tbed.12521-BIB0071|tbed12521-cit-0071","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/bioinformatics\/btu768","article-title":"Evolutionary non-linear modelling for selecting vaccines against antigenically variable viruses","volume":"31","author":"Rahman","year":"2015","journal-title":"Bioinformatics (Oxford, England)"},{"key":"10.1111\/tbed.12521-BIB0072|tbed12521-cit-0072","doi-asserted-by":"crossref","first-page":"e1001027","DOI":"10.1371\/journal.pcbi.1001027","article-title":"Sequence-based prediction for vaccine strain selection and identification of antigenic variability in foot-and-mouth disease virus","volume":"6","author":"Reeve","year":"2010","journal-title":"PLoS Comput. Biol."},{"key":"10.1111\/tbed.12521-BIB0073|tbed12521-cit-0073","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1016\/j.vaccine.2011.05.056","article-title":"Reducing animal experimentation in foot-and-mouth disease vaccine potency tests","volume":"29","author":"Reeve","year":"2011","journal-title":"Vaccine"},{"key":"10.1111\/tbed.12521-BIB0074|tbed12521-cit-0074","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.vaccine.2005.08.071","article-title":"Analysis of the immune response to FMDV structural and non-structural proteins in cattle in Argentina by the combined use of liquid phase and 3ABC-ELISA tests","volume":"24","author":"Robiolo","year":"2006","journal-title":"Vaccine"},{"key":"10.1111\/tbed.12521-BIB0075|tbed12521-cit-0075","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1586\/erv.11.4","article-title":"Development of vaccines toward the global control and eradication of foot-and-mouth disease","volume":"10","author":"Rodriguez","year":"2011a","journal-title":"Expert Rev. Vaccines"},{"key":"10.1111\/tbed.12521-BIB0076|tbed12521-cit-0076","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/vr.160.19.647","article-title":"Evaluation of laboratory tests for SAT serotypes of foot-and-mouth disease virus with specimens collected from convalescent cattle in Zimbabwe","volume":"160","author":"Sammin","year":"2005","journal-title":"Vet. Rec."},{"key":"10.1111\/tbed.12521-BIB0077|tbed12521-cit-0077","unstructured":"Seago , J. 2014 Thermofluor analysis of the FMDV capsid. oral presentation at the EuFMD OPen Session, Cavtat, Croatia 29-31 October 2014"},{"key":"10.1111\/tbed.12521-BIB0078|tbed12521-cit-0078","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1099\/vir.0.043521-0","article-title":"Characterization of epitope-tagged foot-and-mouth disease virus","volume":"93","author":"Seago","year":"2012","journal-title":"J. Gen. Virol."},{"key":"10.1111\/tbed.12521-BIB0079|tbed12521-cit-0079","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0168-1702(02)00262-9","article-title":"Control and eradication of foot-and-mouth disease","volume":"91","author":"Sutmoller","year":"2003","journal-title":"Virus Res."},{"key":"10.1111\/tbed.12521-BIB0080|tbed12521-cit-0080","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/10837450.2013.784335","article-title":"Foot and Mouth Disease virus-loaded fungal chitosan nanoparticles for intranasal administration: impact of formulation on physicochemical and immunological characteristics","volume":"19","author":"Tajdini","year":"2014","journal-title":"Pharm. Dev. Technol."},{"key":"10.1111\/tbed.12521-BIB0081|tbed12521-cit-0081","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1128\/CVI.00034-14","article-title":"Comparison of test methodologies for foot-and-mouth disease virus serotype A vaccine matching","volume":"21","author":"Tekleghiorghis","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1111\/tbed.12521-BIB0082|tbed12521-cit-0082","doi-asserted-by":"crossref","first-page":"11675","DOI":"10.1128\/JVI.01254-12","article-title":"A safe foot-and-mouth disease vaccine platform with two negative markers for differentiating infected from vaccinated animals","volume":"86","author":"Uddowla","year":"2012","journal-title":"J. Virol."},{"key":"10.1111\/tbed.12521-BIB0083|tbed12521-cit-0083","unstructured":"US Department of Homeland Security 2012 \u201cNew foot-and-mouth disease vaccine gets licensed for use on cattle\u201d www.dhs.gov\/publication\/st-piadc-press-release-oct-2012"},{"key":"10.1111\/tbed.12521-BIB0084|tbed12521-cit-0084","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jviromet.2012.06.014","article-title":"A plate-based high-throughput assay for virus stability and vaccine formulation","volume":"185","author":"Walter","year":"2012","journal-title":"J. Virol. Methods"},{"key":"10.1111\/tbed.12521-BIB0085|tbed12521-cit-0085","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.vaccine.2015.01.031","article-title":"Size-exclusion HPLC provides a simple, rapid, and versatile alternative method for quality control of vaccines by characterizing the assembly of antigens","volume":"33","author":"Yang","year":"2015","journal-title":"Vaccine"},{"key":"10.1111\/tbed.12521-BIB0086|tbed12521-cit-0086","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1297-9716-45-62","article-title":"Induction of protective immune response against both PPRV and FMDV by a novel recombinant PPRV expressing FMDV VP1","volume":"45","author":"Yin","year":"2014","journal-title":"Vet. Res."},{"key":"10.1111\/tbed.12521-BIB0087|tbed12521-cit-0087","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1128\/CVI.00127-14","article-title":"Rapeseed Oil and Ginseng Saponins Work Synergistically to Enhance Th1 and Th2 Immune Responses Induced by the Foot-and-mouth Disease Vaccine","volume":"21","author":"Zhang","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1111\/tbed.12521-BIB0088|tbed12521-cit-0088","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1746-6148-10-2","article-title":"Resiquimod and polyinosinic-polycytidylic acid formulation with aluminum hydroxide as an adjuvant for foot-and-mouth disease vaccine","volume":"10","author":"Zhou","year":"2014","journal-title":"BMC Vet. Res."}],"container-title":["Transboundary and Emerging Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftbed.12521","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/tbed.12521\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T15:41:51Z","timestamp":1675957311000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tbed.12521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":87,"URL":"https:\/\/doi.org\/10.1111\/tbed.12521","archive":["Portico"],"relation":{},"ISSN":["1865-1674"],"issn-type":[{"value":"1865-1674","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}